US Patent Issued to Societe des Produits Nestle on July 15 for "Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children" (British Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,647, issued on July 15, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).

"Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children" was invented by Per Torp Sangild (Copenhagen NV, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children."

The patent was filed on April 29, 2021, under Application No. 17/244,437.

*For further information, including images, ...